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Research
Methylmercury (MeHg), a worldwide con-
taminant found in fish and seafood, has been 
linked recently to adverse effects on the cardio- 
vascular system. Increased risk of coronary 
heart disease was found with elevated hair-
mercury concentrations in a cohort of Finnish 
men, whose increased MeHg exposures 
were largely from consumption of fish from 
contaminated lakes (Salonen et al. 1995). 
Association with accelerated progression of 
carotid atherosclerosis, as measured by com-
mon carotid intima-media thickness (IMT), 
was later found in the same Finnish popula-
tion (Salonen et al. 2000). MeHg exposures, 
as reflected by toenail mercury concentra-
tions, were also associated with a higher 
risk of myocardial infarction in a European 
multi center study (Guallar et al. 2002), and 
a similar, although insignificant association 
was found in nondentist health profession-
als in the United States (Yoshizawa et al. 
2002). MeHg-associated increase in blood 
pressures (BPs) was observed in a prospective 
cohort study of Faroese children at 7 years of 
age, and a decrease in heart rate variability 
(HRV), a marker of cardiac autonomic con-
trol, occurred both at 7 and 14 years of age 
(Grandjean et al. 2004; Sørensen et al. 1999). 
These observations suggest that MeHg may 
be an important risk factor for cardiovascu-
lar disease, although results have not been 
consistent (Hallgren et al. 2001). The patho-
genesis of MeHg-associated cardiovascular 
abnor malities is unclear, but it may involve 
neurotoxic effects. Thus, associations between 
HRV and brainstem auditory evoked poten-
tial (BAEP) latencies in MeHg-exposed ado-
lescents suggest a link between cardiovascular 
autonomic tone and brainstem neurotoxicity 
(Grandjean et al. 2004; Murata et al. 2004).
Although MeHg exposure originates from 
contaminated seafood and freshwater fish, 
a high fish intake is also thought to provide 
protective effects against coronary heart dis-
ease (Burr et al. 1989; Mozaffarian and Rimm 
2006; Oomen et al. 2000). Adverse effects of 
MeHg from fish and seafood (levels of which 
vary widely across species; generally fish that 
are high in the food chain have higher MeHg 
concentrations) could therefore counteract 
the benefits from nutrient contents, such as 
omega-3 fatty acids and selenium (National 
Research Council 2000; Salonen et al. 1995). 
Thus, the somewhat equivocal results of 
epidemiologic studies relating fish consump-
tion and cardiovascular events (Marckmann 
and Grønbaek 1999) could be due to inter-
ference from MeHg toxicity. Evidence from 
the few studies that assessed both beneficial 
and adverse cardiovascular effects (Salonen 
et al. 1995; Yoshizawa et al. 2002) support 
this notion.
To explore MeHg-associated effects on 
cardiovascular functions (CVFs), we carried 
out a clinical study of male members of the 
whaling society in the Faroe Islands. This 
Nordic fishing community exhibits a wide 
range of MeHg exposure that primarily origi-
nates from consumption of pilot whale meat; 
other types of seafood contain lower MeHg 
concentrations (Grandjean et al. 1992). 
Members of the Faroese whaling society orga-
nize and participate in the whale drives and 
receive a larger share of the whale meat and 
blubber, although the availability varies across 
islands and over time. We used mercury anal-
yses of hair, blood, and toenail samples to 
ascertain the individual exposure levels and 
also included the result of a hair analysis con-
ducted 7 years earlier. We then used a struc-
tural equation model (SEM) analysis to assess 
the association between the combination of 
MeHg exposure biomarkers on individual 
and groups of outcome variables.
Materials and Methods
Study population. The study population 
originally consisted of 70 male members of 
the Faroese whaling society who had volun-
teered for an exposure examination (hair was 
obtained for mercury analysis) in 1998. The 
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Background: Methylmercury (MeHg), a worldwide contaminant found in fish and seafood, has 
been linked to an increased risk of cardiovascular mortality.
oBjective: We examined 42 Faroese whaling men (30–70 years of age) to assess possible adverse 
effects within a wide range of MeHg exposures from consumption of pilot whale meat.
Methods: We assessed exposure levels from mercury analysis of toenails and whole blood (obtained 
at the time of clinical examination), and a hair sample collected 7 years previously. Outcome meas-
ures included heart rate variability (HRV), blood pressure (BP), common carotid intima-media 
thickness (IMT), and brainstem auditory evoked potentials (BAEP). We carried out multiple regres-
sion and structural equation model (SEM) analyses to determine the confounder-adjusted effect of 
mercury exposure. Taking into account correlations among related measures, we categorized expo-
sure and outcomes in groups to derive latent exposure and response variables in SEMs. We used 
multiple regression analysis to compare the predictive validity of individual exposure biomarkers 
and the latent exposure variable on individual and latent outcomes.
results: The toenail mercury concentrations varied widely and had a geometric mean of 2.0 µg/g; 
hair concentrations averaged about 3-fold higher. Mercury exposure was significantly associated 
with increased BP and IMT. This effect was reflected by SEMs, but mercury in toenails tended to 
be the best effect predictor.
conclusions: The results support the notion that increased MeHg exposure promotes the develop-
ment of cardiovascular disease.
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hair-mercury concentrations varied between 
2.6 and 54.1 µg/g (mean, 15.9 µg/g) and thus 
documented an increased level of exposure 
from frequent consumption of pilot whale 
meat. We invited the subjects for a clinical 
examination in 2005. Sixteen subjects did not 
participate; reasons included death (4), emigra-
tion or long-term travel (6), refusal (4), lost to 
follow-up (1), or exclusion (1 female). Of the 
54 male participants, 42 were between 30 and 
70 years of age. The Faroese Ethical Review 
Committee and the Institutional Review 
Board at the Harvard School of Public Health 
approved the study protocol, and we obtained 
written informed consent from all participants.
As part of a general health examination, 
we recorded relevant covariates based on prior 
knowledge of potential influence on the cardio-
vascular and neurophysiologic outcome vari-
ables (Araki and Murata 1993; Salonen et al. 
2000). Characteristics of the subjects included 
age, smoking history (with three categories: 
past smoker, present smoker, and nonsmoker), 
and body mass index (BMI; calculated as the 
body weight in kilograms per height in meters, 
squared. Weekly alcohol consumption was 
categorized as a) none, b) ≤ 21 drinks, and 
c) > 21 drinks according to the World Health 
Organization (WHO) guidelines (Goldberg 
et al. 2000), where up to 21 drinks per week 
is considered as low level of risk for men. To 
adjust for the nutrient bene fits by fish intake, 
we included in the models the number of fish 
dinners consumed per week in the last year. 
This variable was very similar to the weekly 
fish intake as an adult but with more complete 
data. In addition, we measured fasting serum 
concentrations of cholesterol, cholesterol frac-
tions, and triglycerides.
Measurements of exposure. To ascertain 
long-term exposures to MeHg from food, 
we collected toenails, scalp hair, and whole 
blood for mercury analysis. The toenail 
clippings were collected from all toes and 
washed in a sonicator with deionized water 
before mineraliza tion and analysis. The nor-
mal growth rate for toenails is 3–12 months 
(Karagas et al. 2000). Because toenails incor-
porate mercury during formation but are of 
different lengths, nail clippings taken from all 
toes at the same time reflect the incorporation 
of mercury that has occurred over approxi-
mately 1 year (Yoshizawa et al. 2002). In 
addition to the previously analyzed hair sam-
ple, an additional hair sample was cut from 
the occipital area and the proximal 2 cm were 
used for mercury analysis. Nail clippings and 
hair samples were stored dry at room temper-
ature in a marked paper envelope until analy-
sis. Whole blood was collected in a Venoject 
vial certified to be free of mercury. We used 
flow-injection cold-vapor atomic absorption 
spectrometry after digestion of the samples in 
a microwave oven to ascertain mercury levels 
(Dalgård et al. 1994; Grandjean et al. 1992, 
1995). The relative analytical imprecision for 
this analysis was estimated to be 6.1%, 4.1%, 
and 7.4% at mercury concentrations of 0.35, 
4.6, and 11.7 µg/g, respectively. We ensured 
the accuracy by measuring certified reference 
material BCR 397 (IRMM, Geel, Belgium), 
where our result was 11.74 ± 0.87 µg/g, com-
pared with the certified value of 12.3 ± 0.5 
µg/g. (Mercury concentrations reported in 
units of micrograms may be converted to 
nanomoles by multiplying by 5.0.)
Because pilot whale blubber contains 
elevated concentrations of polychlorinated 
biphenyls (PCBs), we also measured the 
serum concentrations of major PCB conge-
ners. The total PCB concentration was calcu-
lated as twice the sum of congeners 138, 153, 
and 180 and expressed on a lipid-weight basis 
(Heilmann et al. 2006).
Outcome measurements. CVF assessment. 
At a general health examination, the systolic 
and diastolic BPs were measured under stan-
dardized conditions with the subject relaxing 
in a chair. A cuff that covered between one-half 
and two-thirds of the upper arm was applied 
on the left arm, and the pressures were read in 
millimeters of mercury on a sphygmomanom-
eter. Body weight in kilograms was measured 
on an electronic scale to the nearest 100 g. 
Standing height was measured with a stadi-
ometer to the nearest millimeter. All outcome 
parameter assessments were performed blind 
with regard to MeHg exposures.
The R-R intervals (sampling time, 1 msec) 
during 5 min were measured using the Heart 
Rate Monitor S810 and Polar S-series Precision 
Toolkit (Polar, Kempele, Finland), with the 
subject resting in a supine position. Using 
the electrocardiogram (ECG) R-R Interval 
Analyzer (Grandjean et al. 2004; Murata et al. 
2006), 100 consecutive R-R intervals with the 
minimal SD were automatically extracted for 
calculation of the average heart rate and its rela-
tive SD. The coefficient of variation (CVRR) is 
the ratio of the SD of the R-R intervals to the 
average value, and was also expressed as a per-
centage, CVRR% (Grandjean et al. 2004). We 
applied autoregressive spectral analysis to parti-
tion the HRV into independent components 
as indicators for parasympathetic and sympa-
thetic activities (Akselrod 1995; Murata et al. 
1992). The results of the spectral analysis were 
expressed in low-frequency (0.01–0.15 Hz) 
and high-frequency (0.15–0.40 Hz) compo-
nents. We defined the coefficient of variation 
for the low-frequency band (C-CVLF) and 
high-frequency band (C-CVHF) as the ratio 
of the square root of the power spectral den-
sity of each component to the R-R mean. The 
C-CVLF and C-CVHF are thought to reflect 
mainly sympathetic and parasympathetic 
activities, respectively (Grandjean et al. 2004; 
Murata et al. 2006).
The IMT of the carotid arteries was 
assessed as an indicator of carotid athero-
sclerosis (Salonen et al. 2000). The subjects, 
in a supine position, were examined by high-
resolution B-mode ultrasonography of the 
right and left common carotid arteries (CCA) 
in a 1.0–1.5 cm section at the distal end of 
the CCA, which was conducted with the HP 
Sonos 5500 ultrasound system with a trape-
zoidal linear array 3–11 MHz transducer. The 
IMT, assessed by computerized analysis of 
the ultrasound images with a semiautomated 
border detection software, PROSOUND 
(University of Southern California, Los 
Angeles, CA, USA) (Selzer et al. 1994), is 
the mean distance between the intima-lumen 
and media-adventitia interfaces measured at 
approximately 100 points per 1-cm section in 
both the right and left CCAs (Salonen et al. 
2000). We used three measures of IMT for the 
present study: a) mean IMT (the mean of all 
IMT estimates from the left and right CCAs, 
considered an overall measure of the athero-
sclerotic process), b) mean maximal IMT (the 
mean of the points of maximal thickness from 
the right and left CCAs), and c) mean mini-
mal IMT (the mean of the points of minimal 
thickness from the right and left CCAs).
Neurophysiologic assessment. BAEP 
latencies have been linked with MeHg-related 
changes in HRV, possibly reflecting MeHg 
neurotoxicity exerted in brainstem nuclei 
(Grandjean et al. 2004; Murata et al. 2004). 
BAEP assessments were determined in com-
fortably resting subjects using a four-channel 
electromyography (Medelec Sapphire-4ME, 
Surrey, UK). Similar equipment was used pre-
viously with other cohorts (Grandjean et al. 
1997; Murata et al. 2004). Click signals at 
an intensity of 65 dB hearing level (0.1-msec 
impulses of alternating polarity) were presented 
to the right ear through shielded ear phones 
at rates of 20 Hz/sec and 40 Hz/sec indepen-
dently (sampling time, 0.01 msec). The left ear 
was masked with white noise at an intensity 
of 45 dB HL. BAEP latencies were recorded 
by using three standard electro encephalogram 
electrodes placed on the vertex, the right mas-
toid ipsilateral to the stimulation, and the left 
mastoid (ground). The responses were averaged 
2,048 times after amplification and filtration 
(bandpass, 200–2,000 Hz), with replication 
for each rate to calculate average peak latencies. 
Peaks I, III, and V are thought to reflect the 
volume-conducted electric activity from the 
acoustic nerve, pons (superior olivary nucleus), 
and midbrain (inferior colliculi), respectively 
(Murata et al. 2004).
Statistical analyses. The distributions of 
the mercury concentrations were skewed, and 
were therefore log (base 10) transformed. This 
transformation is required by the SEM analy-
sis to obtain approximately linear relation-
ships with homogeneous scatter between the 
Methylmercury exposure and cardiovascular effects
Environmental Health Perspectives • volume 117 | number 3 | March 2009 369
exposure biomarkers. Similarly, most of the 
outcome variables were log transformed except 
for the BP and heart rate variables, which 
approximated a Gaussian distribution. We cal-
culated geometric means for the transformed 
variables and arithmetic means for BPs.
Because of the availability of several expo-
sure parameters and several outcome variables, 
standard regression analysis with confounder 
adjustment was complemented by SEM to 
assess the association between an integrated 
set of biomarkers of mercury exposure on 
the one hand, and sets of cardiovascular and 
neurophysiologic outcomes on the other. 
SEMs have only recently been introduced in 
environmental health research, but detailed 
instructions are available (Bollen 1989; Budtz-
Jørgensen et al. 2002). The observed vari-
ables are considered to be manifestations of a 
smaller number of latent variables (which are 
not available for direct observation but can be 
estimated from the observed variables). In the 
case of mercury exposure, we have
 log(Hgm) = αm + λm log(Hg) + εm, [1]
where Hgm is a marker of mercury exposure, 
and Hg is the “true” (latent) exposure. The log-
transformed mercury biomarker depends lin-
early on the latent (log-transformed) mercury 
exposure and a measurement random error 
(εm). As a starting point, error terms in differ-
ent markers are assumed to be independent. 
We fixed the factor loading λm at 1 for toe-
nail mercury, so that the latent exposure was 
expressed on the scale of the mercury concen-
tration in nails. Hence, a one-unit increase 
in log(Hg) will on average lead to a one-unit 
increase in log nail mercury. αm is the inter-
cept. We fixed this parameter to zero for the 
log nail mercury concentration, indicating that 
the latent exposure also has the same zero point 
as the log nail concentration. The bio markers 
can be compared in terms of both their impre-
cision and their estimated correlations with the 
true exposure (Budtz-Jørgensen et al. 2003). 
The exposure biomarker with the smallest 
imprecision and the highest correlation to the 
latent MeHg exposure is the best indicator.
The relationship between the latent vari-
ables is then considered after adjustment for the 
effects of covariates. SEM analysis allows the 
integration of different measures of exposure 
to generate a latent exposure variable that likely 
provides a closer approximation of the true 
exposure than individual exposure measures 
considered alone. In addition to addressing the 
issue of exposure imprecision, the SEM model 
addresses multiple testing and missing data 
issues that may not be adequately considered by 
standard regression analyses (Budtz-Jørgensen 
et al. 2002). We included information from 
incomplete cases using the maximum likeli-
hood approach (Little and Rubin 2002). 
However, such subjects were excluded in the 
standard regression analysis. For this reason, 
the standard regression models may be inef-
ficient and even biased if information is not 
missing completely at random. Additional 
bias is also possible, because imprecision of the 
exposure assessment is not included.
Likewise, the outcome variables were 
grouped into a small number of latent vari-
ables assumed to reflect broad groupings of 
physiologic functions. The neurophysiologic 
variables were collected into a joint BAEP 
latent variable. The cardiovascular outcomes 
were grouped into heart rate variability, as 
HRV (CVRR%, C-CVLF, and C-CVHF), 
CVF (systolic and diastolic BP, and heart 
rate), and carotid atherosclerosis (mean, maxi-
mal, and minimal IMT).
We constructed a model linking a mer-
cury latent variable with the three cardio-
vascular and the BAEP groupings considered 
as independent latent functions. Potential 
confounders were included in the SEM as 
covariates. PCB was considered as a potential 
additional confounder in separate analyses. 
Adjustment or local dependence between out-
comes in each grouping was considered if the 
correlation between the outcomes could not 
be fully explained by the underlying cardio-
vascular or neurophysiologic functions by 
using the likelihood ratio test (Bollen 1989; 
Budtz-Jørgensen et al. 2002).
To compare the SEM approach with 
linear regression analyses, we used sepa-
rate regression models to assess associations 
between latent and individual mercury expo-
sure parameters and outcomes, after con-
founder adjustment. Because the outcomes 
were not of the same magnitude and trans-
formations had been used, and because the 
loading factors for the two exposure variables 
(mercury in whole-blood and hair samples 
taken 7 years earlier) were lower than that of 
toenail mercury, regression coefficients were 
standardized. Thus, we estimated the change 
(in percentages of the SD of the unadjusted 
outcome parameter) in the outcome associated 
with 1 SD increase in the MeHg exposure 
variable. Two-sided tests for statistical signifi-
cance at p < 0.05 were performed. Descriptive 
analyses and linear regression models were 
carried out in SAS (version 9.1; SAS Institute 
Inc., Cary, NC, USA). SEMs were developed 
in Mplus (version 3.1; Muthen & Muthen, 
Los Angeles, CA, USA).
Results
Table 1 shows the characteristics of the 42 male 
members of the Faroese whaling society exam-
ined in this study. Among the 41 men with 
detailed whale consumption data, 26 (63%) 
consumed three or more whale meals per 
month. We included the binary (yes/no) weekly 
alcohol consumption variable in the models for 
model robustness because the three-categories 
alcohol variable had no significant associations 
with the outcomes and the effects of mercury 
changed only marginally after its inclusion as 
a confounder in the models. Serum concen-
trations of cholesterol and tri glycerides were 
considered normal for the age groups examined 
and were only weakly correlated with indicators 
of mercury exposure (correlations ranged from 
0.07 to 0.16, p > 0.3).
Table 2 shows the geometric mean 
and interquartile range of the mercury 
Table 1. Characteristics of the 42 male members of the Faroese whaling society.
Characteristic Values
Age [years (mean ± SD)] 54.8 ± 9.4
Weight [kg (mean ± SD)] 87.3 ± 10.7
Height [cm (mean ± SD)] 178.5 ± 6.4
BMI (mean ± SD) 27.4 ± 3.2
Smoking [none/past/current (%)] 41/33/26
Alcohol consumption per week [never/≤ 21 drinks/> 21 drinks (%)] 7/71/22
No. of fish dinners pr week [1/2/3–4 (%)] 24/44/32
Serum lipid concentrations [mmol/L (mean ± SD)]
 Total cholesterol 5.74 ± 0.98
 High-density lipoprotein 1.47 ± 0.32 
 Low-density lipoprotein 3.62 ± 0.85
 Triglycerides 1.49 ± 0.99
Table 2. Distribution of mercury and PCB concentrations in specimens used as exposure biomarkers 
among the 42 Faroese whaling men.
    Correlation with
Exposure biomarker Geometric mean Interquartile range Total range toenail mercury
Toenail (µg/g) 2.04 1.35–3.29 0.14–8.26 (1)
Blood (µg/L) 29.5 18.7–46.1 5.19–128.4 0.60
Hair (µg/g)   
 Current 7.31 4.52–13.4 0.92–46.0 0.70
 7 years before 13.9 9.80–21.9 4.80–43.7 0.56
Serum PCBa (µg/g lipid) 10.8 6.6–16.8 1.13–42.4 0.54
aCalculated as twice the sum of PCB congeners 138, 153, and 180.
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concentrations. All exposure biomarkers 
showed relatively wide ranges, where the 
highest mercury concentration was 50-fold 
higher than the lowest in toenails and hair. 
Mercury levels in hair samples taken 7 years 
earlier were higher than the levels of the cur-
rent hair samples. Among the four exposure 
bio markers, mercury in toenails showed the 
closest correlation with hair mercury levels. 
The average ratio of mercury concentrations 
in hair to those in toenails was approximately 
3. The PCB concentrations were compara-
tively high and were positively associated with 
the mercury concentrations (correlation coef-
ficients between 0.47 and 0.54, p < 0.002).
The mean IMT was highly correlated 
with the maximal and minimal measures 
(Table 3). We anticipated the results because 
all three outcomes measured the distance 
from the right and left CCAs but with differ-
ent summary estimates. Likewise, correlations 
between CVRR%, C-CVLF, and C-CVHF 
were high as components of HRV (Table 3). 
The systolic and diastolic BPs correlated well 
(r = 0.79) and were weakly and negatively cor-
related with CVRR. The latencies of peaks III 
and V at 20 Hz and 40 Hz were highly cor-
related (Table 3), and the mean latencies were 
similar to those of a study of Faroese children 
at 14 years of age (Murata et al. 2004).
Mercury concentrations in current hair 
and whole-blood samples were highly corre-
lated (r = 0.94, p < 0.001). To obtain an SEM 
consisting of exposure variables with inde-
pendent error terms, we included the results 
only for toenails, blood, and hair from 7 years 
previously. This model showed that toenail 
measurement had the smallest error compo-
nent. Thus, the toenail mercury biomarker 
had the highest correlation with the estimated 
latent exposure (0.98, compared with 0.83 for 
blood and 0.46 for hair from 7 years before), 
thereby suggesting that it is the best indi-
cator of long-term MeHg exposure in this 
population. When combined with the out-
come variables, the results again showed that, 
among the three mercury biomarkers, toenail 
mercury measurement was the best indicator, 
with the smallest imprecision and the high-
est correlation to the latent MeHg exposure 
(Table 4).
An SEM was constructed to determine 
the overall effect of mercury exposure on the 
groups of outcome variables with adjustment 
for confounders (Figure 1). PCB exposure 
showed no statistically significant associations 
with the outcomes, and inclusion of PCB 
as a confounder in the models changed the 
effects of mercury only marginally. The results 
are therefore reported without PCB adjust-
ment. High correlations among related meas-
ures within this small sample size limited the 
number of outcome variables that could be 
included in latent variables. We included 
all variables shown in Figure 1 in the final 
model (Table 4). Among the HRV indicators, 
CVRR% was the best indicator of the com-
bined outcomes, with the smallest impreci-
sion and the highest correlation to the latent 
HRV variable. Likewise, peak V at 20 Hz 
has slightly better correlation with the latent 
BAEP latent variable. For CVF, the diastolic 
BP and heart rate were the better indicators.
For comparison, results are reported both 
for major individual effect variables and for 
the latent variables (Table 5). We also per-
formed separate models for the latent exposure 
variable with each of the outcome groupings 
and obtained similar results. Among the three 
mercury measures, the coefficients from the 
regression models revealed some differences. 
For the CVRR% outcome, for example, the 
coefficient for the blood concentration was in 
the direction opposite of expectation, but was 
close to zero for other exposure bio markers 
and the latent exposure variable. Similar results 
were obtained with the other two HRV meas-
ures. In contrast, for both CVF and IMT, 
tendencies are similar for the three individual 
exposure parameters and the latent exposure 
variable, thus supporting a causal linkage. The 
confidence intervals for the latent exposure 
interval also take into account the temporal 
variability of the exposures, and the wider 
confidence intervals are reflected by increased 
upper confidence limits. Because standard 
regression analysis fails to take into account 
measurement error in exposure variables, the 
confidence intervals may be too narrow.
Discussion
In this article, we present results on long-term 
MeHg effects on cardiovascular and neuro-
physiologic functions in a small group of men 
exposed to dietary MeHg from whale meat as 
the main seafood source. Our findings suggest 
that MeHg may promote development of car-
diovascular disease, as indicated by increases 
in BP and in IMT. BAEP latencies showed 
slight delays associated with MeHg exposure, 
with wide confidence limits, whereas effects 
on HRV were equivocal.
A major advantage of the present study 
is that we used several exposure biomarkers 
as indicators of long-term MeHg exposure. 
Past studies of adults have used mercury 
concentrations in hair (Salonen et al. 1995, 
2000; Virtanen et al. 2005), blood (Hallgren 
Table 3. Distribution of outcome variables among the 42 Faroese whaling men.
Outcome Geometric mean Interquartile range Total range Correlationa
IMT (mm)  
 Mean 0.82 0.72–0.91 0.60–1.50 (1)
 Maximum 1.09 0.98–1.17 0.78–2.35 0.92
 Minimum 0.58 0.51–0.66 0.41–0.96 0.94
HRV  
 CVRR% 2.99 2.14–4.34 1.26–8.59 (1)
 C-CVLF 1.75 1.29–2.53 0.50–5.25 0.73
 C-CVHF 1.30 0.90–1.77 0.27–3.91 0.79
CVFb  
 Blood pressure (mmHg)   
 Diastolic 85.0 80–90 65–105 (1) 
 Systolic 137.33 125–150 110–199 0.79
 Heart rate (per second) 62.6 56–69 42–81 0.39
BAEP peak latency (msec)  
 20 Hz   
 I 1.82 1.65–1.92 1.57–2.55 0.67 
 III 4.15 3.95–4.32 3.65–4.96 0.85 
 V 6.07 5.85–6.37 5.57–6.74 (1)
 40 Hz   
 I 1.92 1.82–2.02 1.58–2.68 0.58 
 III 4.27 4.05–4.49 3.75–4.92 0.82 
 V 6.21 5.98–6.43 5.69–6.88 0.91
aCorrelation of each variable with the referent variable in each group. bFor BPs and heart rate, the results are given as 
arithmetic means.
Table 4. Factor loadings and estimated correlation 
to each of the latent variables for mercury expo­
sure and outcome groups in an SEM.a
 Factor Correlation to
Outcome loading (λm) latent variable
Hg exposure 
 Toenail (µg/g) (1) 0.98
 Blood (µg/L) 0.68 0.64
 Hair (7 years ago) (µg/g) 0.41 0.57
HRV 
 CVRR% (1) 0.91
 C-CVLF 0.82 0.64
 C-CVHF 1.22 0.86
CVF 
 Diastolic BP (mmHg) (1) 0.61
 Systolic BP (mmHg) 0.99 0.33
 Heart rate (sec–1) 1.06 0.62
BAEP (msec) 
 III 20 Hz 1.44 0.93
 V 20 Hz (1) 0.94
 III 40 Hz 1.37 0.92
 V 40 Hz 0.90 0.90
aThe model (see Figure 1) included confounders (age, 
smoking, alcohol consumption, fish dinners, and BMI), 
latent mercury exposure, and latent outcomes: HRV 
(CVRR%, C­CVLF, C­CVHF), CVF (diastolic and systolic BP, 
and heart rate), and latencies of BAEP (peaks III and V at 
both 20 Hz and 40 Hz).
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et al. 2001), or toenails (Guallar et al. 2002; 
Yoshizawa et al. 2002). Because MeHg has an 
elimination half-life of about 1.5–2 months 
(National Research Council 2000), mercury 
incorporated in growing hair and toenails 
will reflect MeHg intakes during the months 
past (Garland et al. 1993; International 
Programme on Chemical Safety 1990). 
Although standard regression analysis assumes 
that each exposure biomarker is meas ured 
without imprecision, an SEM analysis uses 
integrated information from all available 
exposure biomarkers and takes into account 
the imprecisions originating from both 
labora tory measurement error and biological 
varia tion (Budtz-Jørgensen et al. 2002). If the 
model assumptions are appropriate, the latent 
variable is therefore likely to provide a better 
approximation to the true long-term MeHg 
exposure. Among the individual exposure 
parameters, toenail mercury appears to be the 
most precise biomarker, and the regression 
analyses showed effects of the toenail mercury 
on most of the outcomes that were similar to 
the effects of the latent MeHg exposure.
The SEMs showed clear effects on BP 
and on IMT. The association between MeHg 
exposure and increased BP is consistent with 
previous findings in a Faroese birth cohort 
(Sørensen et al. 1999). MeHg effects on 
carotid atherosclerosis, as measured by IMT, 
were indicated by significant associations with 
toenail and hair mercury concentrations. The 
results support and expand the result of the 
prospective study of Finnish men (Salonen 
et al. 2000).
As a marker of cardiac autonomic con-
trol (Jhun et al. 2003; Magari et al. 2002), 
HRV showed a surprising increase at higher 
blood-mercury concentrations that would 
reflect recent MeHg exposures. We found 
no such tendency for other MeHg exposure 
biomarkers or in the latent exposure variable. 
A lower CVRR has been previously linked to 
increased MeHg exposure in the Faroese birth 
cohort study (Sørensen et al. 1999). However, 
an effect in the opposite direction could con-
ceivably be due to n-3 fatty acids from recent 
seafood intakes (Mozaffarian et al. 2008), thus 
possibly causing confounding with seafood-
derived MeHg exposure.
BAEP latencies appeared to increase, 
although not significantly so, with increasing 
MeHg exposure. Prolonged BAEP latencies 
have been reported to have a direct associ-
ation with MeHg exposure in animal and 
human studies (Chuu et al. 2001; Murata 
et al. 2004). The BAEP effects have been 
linked to exposure-related changes in HRV 
as a joint indication of MeHg neurotoxicity 
exerted in the brainstem nuclei (Grandjean 
et al. 2004; Murata et al. 2004). The pres-
ent study is too small to explore this possible 
pathogenesis.
The Faroese whaling men had minimal 
social differences and exhibited a wide range 
of exposures, thus allowing for the examina-
tion of mercury effects on cardiovascular and 
neurophysiologic outcomes. Although the 
ages of the subjects differed considerably, even 
after exclusion of the very young and the very 
old, age was not significantly associated with 
MeHg exposure. We used HRV, IMT, and 
BP as outcome measures in our study because 
they are all well-established clinical parameters 
and are predictors of increased risk of adverse 
Figure 1. Path diagram for an SEM linking mercury exposure to adverse effects, with adjustment for 
confounders. The estimated true exposure (Hg) is modeled as a latent parameter based on mercury 
concentrations in toenail (N­Hg), blood (B­Hg), and hair sample taken 7 years ago (H­Hg7). Three latent 
effect parameters, HRV, CVF, and latencies of BAEP, are expressed by a series of heart variability, cardio­
vascular, and BAEP (peaks III and V at both 20 and 40 Hz) test results, respectively. HRV, CVF, and BAEP 
may be correlated (indicated by double­headed arrows), and potential confounders are allowed to be 
associated with both the latent exposure variables and the latent effect variables.
Confounders
CVRR%
C­CVLF
C­CVHF
Diastolic BP
Systolic BP
Heart rate
BAEP III 20 Hz
BAEP V 20 Hz
BAEP III 40 Hz
BAEP V 40 Hz
HRV
CVF
BAEP
Log(Hg)
Log(N­Hg)
Log(B­Hg)
Log(H­Hg7)
Table 5. Change in outcome, expressed in percentage of outcome SD (and corresponding 95% confidence 
intervals) associated with 1 SD increase in exposure.a
 Exposure indicator
Outcome Blood Hg Nail Hg Hair Hg (7 years ago) Latent Hg
Latent HRV 24.9 (–0.67 to 50.6)* 11.1 (–19.6 to 42.0) –0.20 (–24.3 to 39.0) 7.80 (–31.7 to 47.3)
 CVRR% 43.3 (20.3 to 66.3)** 25.5 (–0.60 to 51.5)* 25.9 (–1.39 to 53.1)* 5.80 (–29.1 to 40.5)
 C-CVLF 59.2 (31.2 to 87.3)** 42.7 (11.4 to 74.0)** 39.8 (6.26 to 73.5)** 24.1 (–20.0 to 68.2)
 C-CVHF 37.2 (10.7 to 63.9)** 27.6 (–0.29 to 55.5)* 17.2 (–13.1 to 47.5) 9.40 (–22.8 to 41.5)
Latent CVF 23.9 (–12.1 to 60.1) 37.1 (0.46 to 74.3)** 14.5 (–29.3 to 58.0) 38.0 (–5.60 to 81.2)*
 Systolic BP 37.5 (5.12 to 69.9)** 23.3 (–10.4 to 56.1) 22.1 (–13.7 to 58.3) 33.8 (–7.16 to 74.6)
 Diastolic BP 33.2 (3.15 to 62.9)** 30.9 (0.72 to 61.5)** 14.1 (–18.9 to 46.6) 32.4 (–2.58 to 67.2)*
 Heart rate 8.90 (–23.7 to 41.2) 13.3 (–19.4 to 45.7) 17.6 (–16.9 to 52.6) 24.0 (–6.76 to 54.1)
Latent BAEP –5.9 (–33.9 to 22.1) 13.5 (–18.0 to 45.0) 9.50 (–20.1 to 38.0) 2.4 (–25.2 to 28.8)
 III 20 Hz 9.80 (–20.6 to 40.2) 8.20 (–22.8 to 38.2) 26.5 (–5.30 to 58.3) 4.50 (–27.9 to 36.0)
 V 20 Hz 17.5 (–11.1 to 46.1) 19.3 (–8.88 to 47.4) 30.3 (23.0 to 59.6)** 11.3 (–21.2 to 43.8)
 III 40 Hz –7.10 (–36.4 to 23.1) –9.50 (–39.0 to 20.9) 7.70 (–25.2 to 40.6) –11.6 (–44.5 to 21.3)
 V 40 Hz 15.3 (–13.6 to 45.9) 12.3 (–15.4 to 41.6) 32.5 (5.25 to 58.8)** 4.2 (–28.0 to 36.4)
Latent IMTb — — — —
 Mean 25.0 (–5.27 to 55.3) 41.9 (14.2 to 69.6)** 33.6 (3.64 to 63.3)** 29.0 (–3.94 to 61.9)*
 Maximum 16.8 (–16.0 to 49.7) 34.8 (3.99 to 65.6)** 34.3 (2.50 to 66.0)** 24.7 (–10.5 to 59.8)
 Minimum 23.0 (–6.77 to 52.8) 39.0 (11.7 to 66.6)** 29.4 (–0.29 to 59.0)* 24.6 (–7.71 to 56.9)
aAll results in the first row of each latent outcome and in the last column of latent Hg exposure were from SEM analyses. 
All other results were from multiple regression analysis where an individual outcome is regressed on an exposure indi­
cator. Models were adjusted for age, smoking, alcohol consumption, fish dinners, and BMI. bSEM results not available 
because of high correlations among the three similar IMT measures. *p < 0.10; **p < 0.05.
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outcomes, and BAEP latencies are associated 
with HRV variables (Grandjean et al. 2004). 
The small sample size may have affected the 
model stability when attempting to include 
series of outcome data, such as the IMT and 
BPs (some of which were highly correlated) as 
latent variables.
The ratio of mercury concentrations in our 
current hair and blood sample was approxi-
mately 250:1, a finding that is consistent with 
the reported ratio for the human hair-mercury 
concentrations (in micrograms per gram) to 
whole-blood mercury concentrations (in micro-
grams per milli liter) under reasonably constant 
conditions of exposure [Budtz-Jørgensen et al. 
2004; U.S. Environmental Protection Agency 
2001; International Programme on Chemical 
Safety (IPCS) 1990].
The findings of the present study support 
previous studies at lower exposure levels. For 
example, the mean hair mercury concentra-
tions were 1.92 µg/g for a Finnish cohort 
(Salonen et al. 1995), 2.99 µg/g and 0.92 µg/g 
for a Faroese birth cohort at 7 and 14 years of 
age, respectively (Debes et al. 2006, Grandjean 
et al. 1997), and 0.45 µg/g for nail mercury 
levels among a U.S. cohort of nondentist 
health professionals (Yoshizawa et al. 2002). 
In Finnish men, increased risk of cardiovascu-
lar death was seen at hair-mercury concentra-
tions > 2 µg/g (Salonen et al. 1995). Using a 
conversion factor of 3 (Table 2), this exposure 
level corresponds to a toenail concentration 
of about 0.67 µg/g. Studies using toenail- 
mercury concentrations found an increased 
risk of heart disease at toenail mercury con-
centrations greater than 0.66 µg/g (Guallar 
et al. 2002) and 0.84 µg/g (Yoshizawa et al. 
2002). For comparison, the reference dose 
used by the U.S. Environmental Protection 
Agency corresponds to 1 µg/g hair (National 
Research Council 2000), which would trans-
late to about 0.33 µg/g in toenails. Although 
the toenail mercury appears to be a better risk 
indicator than other biomarkers, single mer-
cury concentrations are imprecise measures of 
long-term exposure and will therefore result in 
an underestimated assessment of MeHg toxic-
ity. An SEM provides a stronger and more reli-
able analysis by including all of the available 
measures of exposures and outcomes. In con-
clusion, at highly increased MeHg exposures, 
this study supports the notion that MeHg 
from seafood may promote the development 
of cardio vascular disease.
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